Take a deep breath and delight in the fact that Spring has arrived. As the weather gets warmer (hopefully soon), we can all spend a little more time outside in the sunshine. Personally, I can't wait until I can play tennis outside.

Spring means new beginnings, and in the department of Medicine that also means new faces. Two weeks ago, medical schools across the country celebrated Match Day, when graduating students learned where they'll take up their residencies. We will be welcoming eight new residents into the Med-Peds program, and 38 new residents into the Internal Medicine program, eight of whom graduated from the UR School of Medicine & Dentistry.

We also welcome Patricia Rivera, M.D., who joins us as the division chief of Pulmonary & Critical Care Medicine. She officially begins her new role today. I'm excited to have her on board and look forward to all she will bring to our team. You can read more about our incoming residents and Dr. Rivera in the stories below.

Sending all of you warm wishes for a lovely Spring.

Be well,
Ruth O'Regan, M.D.

Research: Kaval Chhabra. M.Pharm., Ph.D., from the division of Endocrinology, Diabetes & Metabolism, and members of the Chhabra Lab, have published their research "Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity" in the journal Diabetologia.

Appointment: Sonal Munsiff, M.D., from the division of Infectious Diseases, has been selected by the Infectious Diseases Society of America (IDSA) as chair for the multi-society panel for the revision of the "ATS/IDSA/CDC/ERS Drug-Susceptible and Drug-Resistant Tuberculosis Treatment Guidelines." Tuberculosis remains a leading infectious cause of death worldwide. There have been many new innovations in treatment, and the panel will be tasked with updating these international guidelines. A final document is expected by the end of 2023.

Editorial: Edward Walsh, M.D., from the division of Infectious Diseases, co-authored the article "The Challenge of Respiratory Syncytial Virus Human Challenge Studies" in the New England Journal of Medicine.